CN101850055B - Chinese medicament for treating coronary heart diseases - Google Patents

Chinese medicament for treating coronary heart diseases Download PDF

Info

Publication number
CN101850055B
CN101850055B CN2009102383178A CN200910238317A CN101850055B CN 101850055 B CN101850055 B CN 101850055B CN 2009102383178 A CN2009102383178 A CN 2009102383178A CN 200910238317 A CN200910238317 A CN 200910238317A CN 101850055 B CN101850055 B CN 101850055B
Authority
CN
China
Prior art keywords
radix
chinese medicine
parts
chinese
coronary heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102383178A
Other languages
Chinese (zh)
Other versions
CN101850055A (en
Inventor
刘新壮
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102383178A priority Critical patent/CN101850055B/en
Publication of CN101850055A publication Critical patent/CN101850055A/en
Application granted granted Critical
Publication of CN101850055B publication Critical patent/CN101850055B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating coronary heart diseases, and belongs to the field of Chinese medicaments for treating cardiovascular and cerebrovascular system diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as white paeony root, radix rehmanniae, Chinese angelica, cassia twig, glossy ganoderma, radix pseudo-ginseng, dwarf lilyturf tuber, glossy privet fruit and the like. The Chinese medicament has the effects of strengthening body resistance and archaeus, promoting blood circulation by removing blood stasis, nourishing yin and blood and promoting blood circulation and invigorating circulation, and has the advantages of obvious effect, definite curative effect and quick response.

Description

A kind of Chinese medicine for the treatment of coronary heart disease
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Be intended to treat the field of Chinese medicines of coronary heart disease at present, have the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Many patients with coronary heart disease are stood the torment of feeling of oppression and pain in the chest for a long time, face the danger of myocardial infarction, and patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of coronary heart disease, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of coronary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Paeoniae Alba 4-30 part Radix Rehmanniae 4-30 part Radix Angelicae Sinensis 4-30 part
Ramulus Cinnamomi 3-20 part Ganoderma 2-15 part Radix Notoginseng 3-20 part
Radix Ophiopogonis 3-20 part Fructus Ligustri Lucidi 3-20 part
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, the Radix Paeoniae Alba, the Radix Rehmanniae, Radix Angelicae Sinensis, Ramulus Cinnamomi, Radix Ophiopogonis, Fructus Ligustri Lucidi are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma QI invigorating in the side, the body resistance strengthening and constitution consolidating, tonification the five internal organs; The Radix Rehmanniae, the flourish arteries and veins of yin nourishing Radix Ophiopogonis; The Fructus Ligustri Lucidi nourishing kidney yin is 5 with Radix Angelicae Sinensis, the Radix Paeoniae Alba, Radix Notoginseng nourishing blood to suppress the hyperactive liver, Shu Mai invigorates blood circulation; Assistant is with the Ramulus Cinnamomi warming YANG and promoting blood circulation.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, blood circulation promoting and blood stasis dispelling, and nourishing YIN and benefiting blood, the merit of blood circulation and channel invigorating, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Radix Paeoniae Alba 80 gram Radix Rehmanniae 80 gram Radix Angelicae Sinensis 80 grams
Ramulus Cinnamomi 60 kairine sesames 40 gram Radix Notoginseng 60 grams
Radix Ophiopogonis 60, gram Fructus Ligustri Lucidi 60 restrained
Weight in accordance with regulations, with conventional water extraction process the Radix Paeoniae Alba, the Radix Rehmanniae, Radix Angelicae Sinensis, Ramulus Cinnamomi, Radix Ophiopogonis, Fructus Ligustri Lucidi are extracted, make extractum fine powder 126 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 807 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Radix Paeoniae Alba 150 gram Radix Rehmanniae 150 gram Radix Angelicae Sinensis 150 grams
Ramulus Cinnamomi 100 kairine sesames 70 gram Radix Notoginseng 100 grams
Radix Ophiopogonis 100, gram Fructus Ligustri Lucidi 100 restrained
By above-mentioned same method, make 1410 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Radix Paeoniae Alba 300 gram Radix Rehmanniae 300 gram Radix Angelicae Sinensis 300 grams
Ramulus Cinnamomi 200 kairine sesames 150 gram Radix Notoginseng 200 grams
Radix Ophiopogonis 200, gram Fructus Ligustri Lucidi 200 restrained
By above-mentioned same method, make 2857 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
5 parts of 5 parts of Radix Angelicae Sinensis of 5 parts of Radix Rehmanniae of the Radix Paeoniae Alba
4 parts of 3 portions of Radix Notoginseng of 4 portions of Ganodermas of Ramulus Cinnamomi
Radix Ophiopogonis, 4 parts of Fructus Ligustri Lucidi were 4 parts
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts of 25 parts of Radix Angelicae Sinensis of 25 parts of Radix Rehmanniae of the Radix Paeoniae Alba
16 parts of 12 portions of Radix Notoginseng of 16 portions of Ganodermas of Ramulus Cinnamomi
Radix Ophiopogonis, 16 parts of Fructus Ligustri Lucidi were 16 parts
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science coronary heart disease, through 13 routine clinical observations.Selecting tcm diagnosis coronary heart disease is standard: have a delicate constitution, limb is soft weak, and feeling of oppression and pain in the chest is dizzy nervous, the Electrocardioscopy myocardial ischemia.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 6 examples, women's 7 examples do not have other serious disease, and the age is 41 years old-76 years old, 59.6 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, cardiac distresses such as feeling of oppression and pain in the chest are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram obviously improves.
2, effective: body constitution strengthens, and cardiac distresses such as feeling of oppression and pain in the chest are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.13 philtrums of clinical experiment, produce effects 5 people, effective 7 people, invalid 1 people, total effective rate 92.3%.

Claims (1)

1. a Chinese medicine for the treatment of coronary heart disease is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
5 parts of 5 parts of Radix Angelicae Sinensis of 5 parts of Radix Rehmanniae of the Radix Paeoniae Alba
4 parts of 3 portions of Radix Notoginseng of 4 portions of Ganodermas of Ramulus Cinnamomi
Radix Ophiopogonis, 4 parts of Fructus Ligustri Lucidi were 4 parts
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, the Radix Paeoniae Alba, the Radix Rehmanniae, Radix Angelicae Sinensis, Ramulus Cinnamomi, Radix Ophiopogonis, Fructus Ligustri Lucidi are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102383178A 2009-11-18 2009-11-18 Chinese medicament for treating coronary heart diseases Expired - Fee Related CN101850055B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102383178A CN101850055B (en) 2009-11-18 2009-11-18 Chinese medicament for treating coronary heart diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102383178A CN101850055B (en) 2009-11-18 2009-11-18 Chinese medicament for treating coronary heart diseases

Publications (2)

Publication Number Publication Date
CN101850055A CN101850055A (en) 2010-10-06
CN101850055B true CN101850055B (en) 2011-08-17

Family

ID=42801845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102383178A Expired - Fee Related CN101850055B (en) 2009-11-18 2009-11-18 Chinese medicament for treating coronary heart diseases

Country Status (1)

Country Link
CN (1) CN101850055B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688447B (en) * 2012-05-08 2014-04-09 安徽智远生物科技有限公司 Traditional Chinese medicine for treating palpitation and cardiac pain, and preparation method thereof

Also Published As

Publication number Publication date
CN101850055A (en) 2010-10-06

Similar Documents

Publication Publication Date Title
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843755A (en) Chinese medicament for treating diabetic cardiopathy
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843832B (en) Chinese medicament for treating coronary disease
CN101537068B (en) Chinese medicine for treating angina
CN101850017B (en) Chinese medicament for treating asthma
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843758B (en) Chinese medicament for treating coronary disease
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101843793B (en) Chinese medicament for treating tachycardia
CN101849985B (en) Chinese medicament for treating tachycardia
CN101554441A (en) Traditional Chinese medicine for treating coronary heart disease
CN101850054B (en) Chinese medicament for treating diabetic heart diseases
CN101843700A (en) Chinese medicament for treating coronary disease
CN101850034B (en) Chinese medicament for treating angina
CN101843831B (en) Chinese medicament for treating diabetic cardiopathy
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases
CN101843866A (en) Chinese medicament for treating diabetic feet

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD.

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130710

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130710

Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CB03 Change of inventor or designer information

Inventor after: Huang Xiuzhen

Inventor before: Liu Xinzhuang

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20171228

Address after: 274300 Shandong province Shanxian County Huang Gang Zhen Ren Zhuang Xing Zheng Cun Huang Village No. 23

Patentee after: Huang Xiuzhen

Address before: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110817

Termination date: 20181118

CF01 Termination of patent right due to non-payment of annual fee